Great investors · Cathie Wood
Cathie Wood portfolio · Q2 2026
Cathie Wood, founder of ARK Investment Management. This is the stock portfolio ARK Investment Management reported to the SEC (Form 13F) as of Jun 30, 2026, filed on Aug 14, 2026.
The 13F is filed by the firm, not the person: when this page says what Cathie Wood “owns” or “bought”, it means the positions of ARK Investment Management as a whole.
Next 13F: Q3 2026 usually filed ~Nov 12, 2026; deadline Nov 16, 2026. See the quarter page →
Not counted as a concentrated manager: its portfolio is not within 5 to 100 positions; its top 10 positions are under 45%. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
What stocks does Cathie Wood own?
The largest positions of ARK Investment Management in Q2 2026 are TSLA, AMD, SPCX, TEM, HOOD.
- 1TeslaTSLAReduced7.5%
- 2Advanced Micro DevicesAMDReduced5.3%
- 3Space Exploration TechnologiesSPCXNewly listed5.0%
- 4Tempus AITEMIncreased3.8%
- 5Robinhood MarketsHOODReduced3.4%
- 6Crispr TherapeuticsCRSPReduced3.4%
- 7ShopifySHOP3.1%
- 8Twist BioscienceTWSTReduced3.0%
- 9AlphabetGOOG · GOOGLIncreased2.7%
- 1010x GenomicsTXGReduced2.5%
Where there are two tickers (e.g. GOOGL · GOOG) they are two share classes of the same company and the weight is the sum: that is why there are 189 rows here and the 13F has 190 positions.
What did Cathie Wood buy in Q2 2026?
- IncreasedAlphabetGOOG+45% shares · 2.7% of portfolio
- IncreasedEli LillyLLY+509% shares · 0.6% of portfolio
- IncreasedNVIDIANVDA+33% shares · 1.8% of portfolio
- NewSnowflakeSNOW0.4% of portfolio
- IncreasedKratos Defense & Security SolutionsKTOS+34% shares · 1.5% of portfolio
- IncreasedAmazon.comAMZN+17% shares · 2.5% of portfolio
- IncreasedMeta PlatformsMETA+55% shares · 0.9% of portfolio
- IncreasedIntellia TherapeuticsNTLA+16% shares · 1.9% of portfolio
What did Cathie Wood sell in Q2 2026?
- ReducedAdvanced Micro DevicesAMD−48% shares · 5.3% of portfolio
- ReducedRokuROKU−84% shares · 0.5% of portfolio
- ReducedTeradyneTER−48% shares · 2.0% of portfolio
- ReducedTwist BioscienceTWST−28% shares · 3.0% of portfolio
- ReducedCrispr TherapeuticsCRSP−16% shares · 3.4% of portfolio
- ReducedBaiduBIDU−73% shares · 0.2% of portfolio
- ReducedRobinhood MarketsHOOD−13% shares · 3.4% of portfolio
- ReducedTaiwan Semiconductor ManufacturingTSM−23% shares · 1.5% of portfolio
47 positions opened or added to and 49 trimmed or closed, against the previous quarter's 13F. Each is measured the same way across the page: how much the share count changed and its weight in the portfolio today (share classes of the same company added together). The 13F has 181 positions with a change, 8 of them material (0.5 points of the portfolio or more). All full exits are listed, even those that moved less than 0.5 points of the portfolio.
Declared options (1)
Besides stocks, ARK Investment Management declared 1 call (they gain if it rises) with a notional of $719K. The 13F reports the value of the underlying shares, not the premium paid, so these figures look large and are not added to the portfolio. Nor does it say whether the option is bought or written, or its strike or expiry: it may be a hedge.
- CALLARK Innovation ETFARKK$719K
Source: SEC 13F filings show the portfolio at quarter end and are filed up to 45 days later: positions may have changed. They only cover U.S.-listed stocks and some others; no short positions or cash. Not investment advice.